Status:
NOT_YET_RECRUITING
Cost Profile and Budget Implications of Rechargeable Versus Non-rechargeable Sacral Neuromodulation Devices for Neurogenic Lower Urinary Tract Dysfunction
Lead Sponsor:
Qilu Hospital of Shandong University
Collaborating Sponsors:
Aerospace Center Hospital
Shandong Provincial Hospital
Conditions:
Rechargeable Sacral Neuromodulation Device
Neurogenic Lower Urinary Tract Dysfunction
Eligibility:
All Genders
Brief Summary
Traditional sacral neuromodulation devices are not rechargeable. In recent years, new rechargeable sacral neuromodulation devices have been developed and put into the market. The aim of this study was...
Detailed Description
From August 2020 to January 2025, 41 rechargeable and 227 non-rechargeable SNM patients with neurogenic lower urinary tract dysfunction in ten centers were enrolled in this study. Demographic data, SN...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- male and female patients with neurogenic lower urinary tract dysfunction who had failed conventional treatment
- obstructive urinary retention and contraindications to SNM
Exclusion
Key Trial Info
Start Date :
October 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 30 2026
Estimated Enrollment :
268 Patients enrolled
Trial Details
Trial ID
NCT07173517
Start Date
October 1 2025
End Date
April 30 2026
Last Update
September 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Qilu Hospital
Jinan, Shandong, China